Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2019-10-04 2019-10-04
Drug Identification Number 02392852 02392852
Brand name RAN-PREGABALIN RAN-PREGABALIN
Common or Proper name RAN-PREGABALIN RAN-PREGABALIN
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients PREGABALIN PREGABALIN
Strength(s) 225MG 225MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-11 2019-09-11
Estimated end date 2019-09-30 2019-09-30
Actual end date 2019-09-27 2019-09-27
Shortage status Resolved Resolved
Company comments Pack size discontinued Pack size discontinued
Health Canada comments